MDxHealth SA (MDXH)
0.6972
-0.02
(-2.28%)
USD |
NASDAQ |
Sep 09, 16:00
0.6972
0.00 (0.00%)
After-Hours: 17:45
MDxHealth Shareholders Equity (Quarterly) : -30.40M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -30.40M |
| March 31, 2026 | -20.23M |
| December 31, 2025 | -12.09M |
| September 30, 2025 | -8.263M |
| June 30, 2025 | -0.883M |
| March 31, 2025 | 5.968M |
| December 31, 2024 | 14.84M |
| Date | Value |
|---|---|
| September 30, 2024 | 16.99M |
| June 30, 2024 | -8.812M |
| March 31, 2024 | -0.973M |
| December 31, 2023 | 7.208M |
| September 30, 2023 | 17.84M |
| June 30, 2023 | 26.66M |
| March 31, 2023 | 37.65M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Myriad Genetics, Inc. | 303.90M |
| BioRestorative Therapies, Inc. | 3.026M |
| CareDx, Inc. | 425.60M |
| Natera, Inc. | 1.821B |
| Exagen, Inc. | 12.22M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 132.09M |
| Total Liabilities (Quarterly) | 162.49M |
| Debt to Equity Ratio | -3.481 |
| Current Ratio | 1.150 |
| Net Debt Paydown Yield | -20.74% |